SOFOSBUVIR IN THE LEAD


vertex_largeJust as I suspected, Gilead Science is going to be the big ticket winner in the race to kill the bug. Here’s an update on the field of competitors. The smart money says to buy some Gilead stock. I got in at $61 several weeks ago. 

About asknod

VA claims blogger
This entry was posted in HCV Health, Medical News and tagged , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.